BAJAJ BROKING

Notification close image
No new Notification messages
card image
Smartworks Coworking Spaces IPO is Open!
Apply for the Smartworks Coworking Spaces IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

How to Apply for Anthem Biosciences IPO?

To apply for the Anthem Biosciences IPO, investors need to log in to their trading account through a registered broker’s online platform. Within the IPO section, select “Anthem Biosciences IPO” from the active listings. Choose the number of lots, keeping in mind the minimum lot size of 26 shares, and enter the desired bid price within the specified price band of ₹540 to ₹570 per share. Enter your UPI ID for payment authorisation and ensure sufficient funds are available in your linked bank account. Carefully review all details and submit the application. It is important to approve the UPI mandate before 5 PM on July 16, 2025, to complete the process successfully.

For complete details on this public offering, visit the Anthem Biosciences IPO page on Bajaj Broking’s website.

Anthem Biosciences IPO Application Process

The Anthem Biosciences IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:

Step 1: Login to Your Trading Platform

Access your trading account using Bajaj Broking’s app or website.

Step 2: Navigate to the IPO Section

Go to the IPO section to view active IPO listings.

Step 3: Select the Open IPO and Click Apply

Locate Anthem Biosciences IPO in the list of available IPOs and click the ‘Apply’ button.

Step 4: Enter the Quantity of Shares You Wish to Apply For

Specify the number of shares (minimum lot size: 26 shares) within the price band of ₹540 to ₹570 per share.

Step 5: Provide Your UPI ID

Enter your UPI ID for payment authorization and ensure sufficient funds in your bank account.

Step 6: Confirm the Application

Review your application details and confirm the UPI mandate before 5 PM on the last application day.

Step 7: Complete the Process and Wait for Allotment

Submit the application and monitor the allotment status to check if shares have been allocated to you.

Additional Read:  Anthem Biosciences IPO Investment Guide: Objectives & Opportunities

About Anthem Biosciences IPO: Overview and Key Facts

Anthem Biosciences Limited, launched in 2006, offers integrated services in contract research, development, and manufacturing (CRDMO). Its operations span from early-stage drug discovery and development to commercial manufacturing. The company serves a global client base, including both emerging biotechnology firms and established pharmaceutical companies. Its core product lineup focuses on fermentation-derived active pharmaceutical ingredients (APIs), such as enzymes, peptides, vitamin analogues, probiotics, and biosimilars. Anthem’s platform covers multiple therapeutic modalities—RNA interference (RNAi), antibody-drug conjugates (ADC), peptides, lipids, and oligonucleotides—supported by four manufacturing technologies including fermentation and flow chemistry.


As of late September 2024, Anthem Biosciences was handling nearly two hundred projects across discovery, early and late-stage development, and commercial phases. The initiative includes support for ten commercial molecules, spanning discovery to production. The company’s global footprint extends across more than 44 countries, with clients in North America, Europe, Japan, and beyond. Anthem holds patents in India and abroad, and has filed additional patent applications in areas such as glycolipid synthesis and GLP‑1 analogues, indicating ongoing investment in proprietary processes and innovation.

The Anthem Biosciences IPO will be open for subscription from July 14 to July 16, 2025, with a price range set between ₹540 and ₹570 per share. Investors may apply in multiples of 26 shares per lot; retail applications start from one lot. The IPO involves the offer for sale of nearly 596 million shares aggregating to approximately ₹3,395 crore, and will be listed on both BSE and NSE. The registrar handling the issue is Kfin Technologies Limited, with JM Financial as the lead manager. Key dates include allotment on July 17, initiation of refunds and share credits on July 18, and tentative listing on July 21, pending regulatory clearance.

To check your application status, visit the Anthem Biosciences IPO Allotment Status page on Bajaj Broking’s website.

Share this article: 

Frequently Asked Questions

No result found

search icon

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4.2 App Rating

icon-with-text

4 Languages

icon-with-text

₹5600+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|